AXSM vs EPAM · rev $409.6M vs P/E 14, rev $2.81B
Axsome Therapeutics Inc (AXSM) versus EPAM Systems Inc (EPAM) — a side-by-side from cached financials, not a winner call.
Axsome Therapeutics Inc (AXSM) is a biotechnology company listed on US.
EPAM Systems Inc (EPAM) is a information technology services company listed on US.
Latest reported AXSM revenue for 2026-06-30 was $409.6M. Net income was -$115.9M. AXSM currently screens at market cap $11.96B.
Latest reported EPAM revenue for 2026-06-30 was $2.81B. Net income was $185.5M. EPAM currently screens at market cap $5.10B and trailing P/E 14.0.
AXSM currently screens at market cap $11.96B. EPAM currently screens at market cap $5.10B and trailing P/E 14.0.
Not investment advice. Open the AXSM and EPAM stock pages for the full models.
Not investment advice.